Skip to search
Skip to main content
Back to Search
Start Over
BNT211-01: A phase I trial to evaluate safety and efficacy of CLDN6 CAR T cells and CLDN6-encoding mRNA vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumours
Authors :
Mackensen, A. Haanen, J. B. A. G. Koenecke, C. Alsdorf, W. Wagner-Drouet, E. Heudobler, D. Borchmann, P. Bokemeyer, C. Klobuch, S. Smit, E. Mueller, F. Desuki, A. Lueke, F. Wiegert, E. Flemmig, C. Schulz-Eying, C. Rengstl, B. Preussner, L. Tuereci, O. Sahin, U. Mackensen, A. Haanen, J. B. A. G. Koenecke, C. Alsdorf, W. Wagner-Drouet, E. Heudobler, D. Borchmann, P. Bokemeyer, C. Klobuch, S. Smit, E. Mueller, F. Desuki, A. Lueke, F. Wiegert, E. Flemmig, C. Schulz-Eying, C. Rengstl, B. Preussner, L. Tuereci, O. Sahin, U.
Publication Year :
2022
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1383744801
Document Type :
Electronic Resource